BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 21456294)

  • 1. Release of adriamycin from poly(lactide-co-glycolide)-polyethylene glycol nanoparticles.
    Mo SM; Oh IJ
    J Nanosci Nanotechnol; 2011 Feb; 11(2):1795-8. PubMed ID: 21456294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adriamycin release from poly(lactide-coglycolide)-polyethylene glycol nanoparticles: synthesis, and in vitro characterization.
    Davaran S; Rashidi MR; Pourabbas B; Dadashzadeh M; Haghshenas NM
    Int J Nanomedicine; 2006; 1(4):535-9. PubMed ID: 17722284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Docetaxel-loaded PLGA and PLGA-PEG nanoparticles for intravenous application: pharmacokinetics and biodistribution profile.
    Rafiei P; Haddadi A
    Int J Nanomedicine; 2017; 12():935-947. PubMed ID: 28184163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. pH-sensitive nanoparticles of poly(L-histidine)-poly(lactide-co-glycolide)-tocopheryl polyethylene glycol succinate for anti-tumor drug delivery.
    Li Z; Qiu L; Chen Q; Hao T; Qiao M; Zhao H; Zhang J; Hu H; Zhao X; Chen D; Mei L
    Acta Biomater; 2015 Jan; 11():137-50. PubMed ID: 25242647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation and in vitro evaluation of doxorubicin-loaded Fe₃O₄ magnetic nanoparticles modified with biocompatible copolymers.
    Akbarzadeh A; Mikaeili H; Zarghami N; Mohammad R; Barkhordari A; Davaran S
    Int J Nanomedicine; 2012; 7():511-26. PubMed ID: 22334781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using doxorubicin and siRNA-loaded heptapeptide-conjugated nanoparticles to enhance chemosensitization in epidermal growth factor receptor high-expressed breast cancer cells.
    Liu CW; Lin WJ
    J Drug Target; 2013 Sep; 21(8):776-86. PubMed ID: 23829387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and characterization of hyaluronic acid-anchored PLGA nanoparticulate carriers of doxorubicin.
    Yadav AK; Mishra P; Mishra AK; Mishra P; Jain S; Agrawal GP
    Nanomedicine; 2007 Dec; 3(4):246-57. PubMed ID: 18068091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor necrosis factor alpha blocking peptide loaded PEG-PLGA nanoparticles: preparation and in vitro evaluation.
    Yang A; Yang L; Liu W; Li Z; Xu H; Yang X
    Int J Pharm; 2007 Feb; 331(1):123-32. PubMed ID: 17097246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced cellular uptake of folic acid-conjugated PLGA-PEG nanoparticles loaded with vincristine sulfate in human breast cancer.
    Chen J; Li S; Shen Q; He H; Zhang Y
    Drug Dev Ind Pharm; 2011 Nov; 37(11):1339-46. PubMed ID: 21524153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endostar-loaded PEG-PLGA nanoparticles: in vitro and in vivo evaluation.
    Hu S; Zhang Y
    Int J Nanomedicine; 2010 Nov; 5():1039-48. PubMed ID: 21170352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rational Design of Multifunctional Polymeric Nanoparticles Based on Poly(l-histidine) and d-α-Vitamin E Succinate for Reversing Tumor Multidrug Resistance.
    Li Z; Chen Q; Qi Y; Liu Z; Hao T; Sun X; Qiao M; Ma X; Xu T; Zhao X; Yang C; Chen D
    Biomacromolecules; 2018 Jul; 19(7):2595-2609. PubMed ID: 29618203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversion of Multidrug Resistance by Co-Encapsulation of Doxorubicin and Metformin in Poly(lactide-co-glycolide)-d-α-tocopheryl Polyethylene Glycol 1000 Succinate Nanoparticles.
    Shafiei-Irannejad V; Samadi N; Salehi R; Yousefi B; Rahimi M; Akbarzadeh A; Zarghami N
    Pharm Res; 2018 Apr; 35(6):119. PubMed ID: 29671072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Andrographolide-loaded PLGA-PEG-PLGA micelles to improve its bioavailability and anticancer efficacy.
    Zhang J; Li Y; Gao W; Repka MA; Wang Y; Chen M
    Expert Opin Drug Deliv; 2014 Sep; 11(9):1367-80. PubMed ID: 24935153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation and evaluation of tacrolimus-loaded nanoparticles for lymphatic delivery.
    Shin SB; Cho HY; Kim DD; Choi HG; Lee YB
    Eur J Pharm Biopharm; 2010 Feb; 74(2):164-71. PubMed ID: 19703559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and characterization of sorafenib-loaded PLGA nanoparticles for the systemic treatment of liver fibrosis.
    Lin TsT; Gao DY; Liu YC; Sung YC; Wan D; Liu JY; Chiang T; Wang L; Chen Y
    J Control Release; 2016 Jan; 221():62-70. PubMed ID: 26551344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PLGA-PEG-PLGA triblock copolymeric micelles as oral drug delivery system: In vitro drug release and in vivo pharmacokinetics assessment.
    Chen X; Chen J; Li B; Yang X; Zeng R; Liu Y; Li T; Ho RJY; Shao J
    J Colloid Interface Sci; 2017 Mar; 490():542-552. PubMed ID: 27923139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Docetaxel-loaded nanoparticles based on star-shaped mannitol-core PLGA-TPGS diblock copolymer for breast cancer therapy.
    Tao W; Zeng X; Liu T; Wang Z; Xiong Q; Ouyang C; Huang L; Mei L
    Acta Biomater; 2013 Nov; 9(11):8910-20. PubMed ID: 23816645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A mPEG-PLGA-b-PLL copolymer carrier for adriamycin and siRNA delivery.
    Liu P; Yu H; Sun Y; Zhu M; Duan Y
    Biomaterials; 2012 Jun; 33(17):4403-12. PubMed ID: 22436800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nuclear-targeting TAT-PEG-Asp8-doxorubicin polymeric nanoassembly to overcome drug-resistant colon cancer.
    Pan ZZ; Wang HY; Zhang M; Lin TT; Zhang WY; Zhao PF; Tang YS; Xiong Y; Zeng YE; Huang YZ
    Acta Pharmacol Sin; 2016 Aug; 37(8):1110-20. PubMed ID: 27292613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On the synthesis of mucus permeating nanocarriers.
    Bourganis V; Karamanidou T; Samaridou E; Karidi K; Kammona O; Kiparissides C
    Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):239-49. PubMed ID: 25661586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.